fig4
![Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance](https://image.oaes.cc/0cffa162-f30c-49b6-ab6a-0d4c633ebeb2/3763.fig.4.jpg)
Figure 4. In vitro DOX release from DOX-NPs and GC DOX-NPs with DOX solution as control, up to 24 h. Each point represents the mean ± SD of three different formulations. DOX: doxorubicin hydrochloride; GC: glycol chitosan-coated; DOX-NPs: DOX-loaded nanoparticles